HealthUnlockedHealthUnlocked
AboutLog in

Experiences with

Alemtuzumab

  • Posts

  • Communities

15 public posts

Has anyone in the group tried Lemtrada (Alemtuzumab)

Hello all :) Has someone in this group tried Lemtrada & has it helped you? How long has it been since you finished your second year of Lemtrada
Hello all :) Has someone in this group tried Lemtrada & has it helped you? How long has it been since you finished your second year of Lemtrada
Timmy0903 profile image
Timmy0903
in My MSAA Community
11 months ago

Antiphospholipid Antibodies Overlapping in Isolated Neurological Syndrome and Multiple Sclerosis: Neurobiological Insights & Diagnostic . .

Front Cell Neurosci. 2019; 13: 107. Published online 2019 Mar 19. doi: 10.3389/fncel.2019.00107 Antiphospholipid Antibodies Overlapping in Isolated Neurological Syndrome and Multiple Sclerosis: Neurobiological Insights and Diagnostic Challenges Chiara D’Angelo,1,2,3 Oriol Franch,4 Lidia
Front Cell Neurosci. 2019; 13: 107. Published online 2019 Mar 19. doi: 10.3389/fncel.2019.00107 Antiphospholipid Antibodies Overlapping in Isolated Neurological Syndrome and Multiple Sclerosis: Neurobiological Insights and Diagnostic Challenges Chiara D’Angelo,1,2,3 Oriol Franch,4 Lidia
lupus-support1 profile image
lupus-support1
Administratorin LUpus Patients Understanding and Support
3 years ago

Vaccines FYI

Some MS therapies, including steroids and disease-modifying therapies like Lemtrada (alemtuzumab), Tysabri (natalizumab), and Gilenya (fingolimod), are associated with diminished effectiveness of vaccines and a risk of infection as well.
Some MS therapies, including steroids and disease-modifying therapies like Lemtrada (alemtuzumab), Tysabri (natalizumab), and Gilenya (fingolimod), are associated with diminished effectiveness of vaccines and a risk of infection as well.
sashaming1 profile image
sashaming1
in My MSAA Community
4 years ago
Want to take advantage of all our features? Just log in!
or

Campath/ Alemtuzumab

Hi Has anyone been treated with the above medication (I have given both names for it). If you have how was it?and did it work for you? I think I am running out of drug options/ combinations now, and platelets remain at 0. This is the doctors next plan but the hospital have only ever treated 3 people
Hi Has anyone been treated with the above medication (I have given both names for it). If you have how was it?and did it work for you? I think I am running out of drug options/ combinations now, and platelets remain at 0. This is the doctors next plan but the hospital have only ever treated 3 people
Kazpig1 profile image
Kazpig1
in ITP Support Association
6 years ago

Looking for other teachers (particularly a couple who have also had campath/Alemtuzumab)

Hi Realise this is very specific but know from here and was also told on G2 (Infusion bay at Addenbrookes - formally PSSU) that there are a couple of other teachers out there whose Behcet's has been tackled with campath. I would love to link up. I've just finished my fourth course of campath yesterday
Hi Realise this is very specific but know from here and was also told on G2 (Infusion bay at Addenbrookes - formally PSSU) that there are a couple of other teachers out there whose Behcet's has been tackled with campath. I would love to link up. I've just finished my fourth course of campath yesterday
Zebra profile image
Zebra
in Behçet's UK
6 years ago

Has anyone disgnosed with Churg Strauss Syndrome (EGPA) has experience of taking Alemtuzmab (Campath)

Question from the face book group if anyone can help Just wondering if anybody has had - Alemtuzumab Dr David Jayne has put me forwards for it. I have to wait until June, 6 months clear of Rituximab but hopefully I will finally be able to get things under control with this new one...
Question from the face book group if anyone can help Just wondering if anybody has had - Alemtuzumab Dr David Jayne has put me forwards for it. I have to wait until June, 6 months clear of Rituximab but hopefully I will finally be able to get things under control with this new one...
Suzym2u profile image
Suzym2u
Vasculitis UKin Vasculitis UK
8 years ago

Merely an Accounting Problem

Martin Lockwood treated me with a drug then called Campath, (Alemtuzumab) at Addenbrooke’s Hospital Cambridge. I was suffering with Wegener’s Granulomatosis. Since then the Vasculitis Clinic at Addenbrooke’s now headed by Dr.
Martin Lockwood treated me with a drug then called Campath, (Alemtuzumab) at Addenbrooke’s Hospital Cambridge. I was suffering with Wegener’s Granulomatosis. Since then the Vasculitis Clinic at Addenbrooke’s now headed by Dr.
Howget profile image
Howget
in Vasculitis UK
9 years ago

The convoluted history of Campath and when side effects can be useful

Coles, the first author of two papers describing phase 3 trials of alemtuzumab for Multiple Sclerosis.)
Coles, the first author of two papers describing phase 3 trials of alemtuzumab for Multiple Sclerosis.)
AussieNeil profile image
AussieNeil
Administratorin CLL Support
9 years ago

Lemtrada (Alemtuzumab) for Multiple Sclerosis - and thyroid issues

Lemtrada is another name for Alemtuzumab. This is the Wiki article on it: http://en.wikipedia.org/wiki/Alemtuzumab Rod Image is taken from Wiki article.
Lemtrada is another name for Alemtuzumab. This is the Wiki article on it: http://en.wikipedia.org/wiki/Alemtuzumab Rod Image is taken from Wiki article.
helvella profile image
helvella
Thyroid UKin Thyroid UK
10 years ago

Chlorambucil may be a more reasonable choice for elderly CLL patients than fludarabine.

Alemtuzumab consolidation did not provide benefit over similar regimens without alemtuzumab, irrespective of age." Neil
Alemtuzumab consolidation did not provide benefit over similar regimens without alemtuzumab, irrespective of age." Neil
AussieNeil profile image
AussieNeil
Administratorin CLL Support
10 years ago

Had Fludarabine? You can only have irradiated blood...for life.

Irradiated blood components should be used after alemtuzumab (anti-CD52) therapy. Their use after rituximab (anti-CD20) is not recommended at this time.
Irradiated blood components should be used after alemtuzumab (anti-CD52) therapy. Their use after rituximab (anti-CD20) is not recommended at this time.
Cllcanada profile image
Cllcanada
Top Poster CURE Heroin CLL Support
10 years ago

Doctors should use different therapies when treating older and younger CLL patients

Alemtuzumab, aka Campath, ,consolidation therapy after chemotherapy or chemoimmunotherapy does not improve progression-free or overall survival in either younger or older patients.' Article...
Alemtuzumab, aka Campath, ,consolidation therapy after chemotherapy or chemoimmunotherapy does not improve progression-free or overall survival in either younger or older patients.' Article...
Cllcanada profile image
Cllcanada
Top Poster CURE Heroin CLL Support
10 years ago

An update on where and what Vasculitis UK are about at the moment...

VUK also play an active role in the UK Vasculitis Rare Disease Working Group In terms of current research funding, VUK are supporting trials at Addenbrookes Hospital, Cambridge of a new drug for the treatment of vasculitis, Alemtuzumab as well as a project at Birmingham Wellcome Trust Clinical Research
VUK also play an active role in the UK Vasculitis Rare Disease Working Group In terms of current research funding, VUK are supporting trials at Addenbrookes Hospital, Cambridge of a new drug for the treatment of vasculitis, Alemtuzumab as well as a project at Birmingham Wellcome Trust Clinical Research
John_Mills profile image
John_Mills
Vasculitis UKin Vasculitis UK
11 years ago

Has anyone any experience of taking Campath? (Alemtuzumab)

We have received an email today asking about Campath. This lady is about to start a course of treatment and is obviously very concerned.
We have received an email today asking about Campath. This lady is about to start a course of treatment and is obviously very concerned.
John_Mills profile image
John_Mills
Vasculitis UKin Vasculitis UK
11 years ago

Vasculitis-uk support research at Addenbrookes for a new drug trial for treatment of vasculitis.

Dr David Jayne's team led by Dr Rona Smith at Addenbrookes are undertaking research into an existing drug, Alemtuzumab, to see if it proves to be effective in treating ANCA related vasculitis. Alemtuzumab, which is one of the new generation of monoclonal antibodies, like Rituximab.
Dr David Jayne's team led by Dr Rona Smith at Addenbrookes are undertaking research into an existing drug, Alemtuzumab, to see if it proves to be effective in treating ANCA related vasculitis. Alemtuzumab, which is one of the new generation of monoclonal antibodies, like Rituximab.
John_Mills profile image
John_Mills
Vasculitis UKin Vasculitis UK
12 years ago
    Filter results
    Posted in
    Sort by
    HealthUnlocked
    © 2023 All rights reserved.

    Company

    • About Us
    • Partner with us
    • Careers

    Product

    • Health terms A to Z
    • Communities A to Z
    • Start a Community

    Support

    • Contact us